Krystal Biotech, Inc. (KRYS)

NASDAQ: KRYS · Real-Time Price · USD

341.12

-25.73 (-7.01%)

At close: Jul 31, 2026, 4:00 PM EDT

340.00

-1.12 (-0.33%)

After-hours: Jul 31, 2026, 7:40 PM EDT

Krystal Biotech Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	225.03	204.83	89.16	10.93	-139.98	-69.57
Depreciation & Amortization	6.64	6.55	6.71	5.91	3.39	2.77
Stock-Based Compensation	54.65	54.51	49.13	39.93	33.23	15.32
Other Adjustments	-5.4	-28.61	-7.12	-107.06	0.13	1.04
Change in Receivables	-23.55	-22.12	-62.71	-42.04	-	-
Changes in Inventories	-5.13	-6.29	-11.91	-4.48	-	-
Changes in Accounts Payable	0.94	0.83	1.01	-0.1	-1.25	0.71
Changes in Accrued Expenses	27.45	4.12	67.47	10.54	5.17	2.71
Changes in Other Operating Activities	-0.52	-12.96	-8.32	-2.44	-1.26	-0.91
Operating Cash Flow	250.28	200.87	123.42	-88.8	-100.57	-47.94
Operating Cash Flow Growth	80.70%	62.75%	-	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Capital Expenditures	-12.9	-11.95	-4.24	-11.8	-52.98	-68.34
Sale of Property, Plant & Equipment	-0.44	-	0.44	-	-	-
Proceeds from Sale of Intangible Assets	-	-	-	100	-	-
Purchases of Investments	-444.77	-422.54	-457.74	-508.78	-318.78	-190.46
Proceeds from Sale of Investments	390.43	375.64	298.54	503.21	257.68	32.03
Investing Cash Flow	-67.23	-58.42	-163.44	82.64	-114.08	-226.77

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Issuance of Common Stock	27.7	22.66	32.4	203.5	36	355.65
Repurchase of Common Stock	-16.99	-13.96	-5.39	-0.75	-0.65	-
Net Common Stock Issued (Repurchased)	10.71	8.71	27.01	202.75	35.35	355.65
Other Financing Activities	-	-	-	-	-	-7.96
Financing Cash Flow	10.71	8.71	27.01	202.75	35.35	347.69

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Foreign Exchange Rate Adjustments	-1.22	0.29	-0.46	-0.16	-0.04	-
Net Cash Flow	192.54	151.44	-13.46	196.43	-179.35	72.98

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	237.38	188.91	119.18	-100.6	-153.55	-116.27
Free Cash Flow Growth	83.56%	58.51%	-	-	-	-
FCF Margin	56.88%	48.55%	41.02%	-198.43%	-	-
Free Cash Flow Per Share	7.89	6.31	4.01	-3.63	-6.02	-5.24
Levered Free Cash Flow	241.51	185.14	139.88	8.56	-186.91	-132.63
Unlevered Free Cash Flow	210.39	154.68	112.2	-95.29	-192.13	-131.34

SEC Filings: 10-K · 10-Q